PND16 MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMERS DISEASE IN GERMANY
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72597-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72597-9/fulltext
Title :
PND16 MODELING THE CLINICAL AND ECONOMIC IMPLICATIONS OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMERS DISEASE IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72597-9&doi=10.1016/S1098-3015(11)72597-9
First page :
A390
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
756